Why the study?
Analytical characterization of gene therapy products remains challenging due to their large size, structural complexity, heterogeneity, potential instability, and limited sample availability.
Design
Review
Authors
Loading...
Highlights need for fit-for-purpose analytics in gene therapy QC; leaves open standardization for complex, heterogeneous products.
Key points are not available for this paper at this time.
Fekete et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: